CAMK4 (Calcium/Calmodulin-Dependent Kinase 4, also known as CaMKIV) is a serine/threonine protein kinase that plays a critical role in linking calcium signaling to gene transcription in neurons and immune cells. As one of four members of the CaM kinase family (CAMK1, CAMK2, CAMK4, CAMK5), CAMK4 uniquely localizes to the nucleus where it phosphorylates transcription factors including CREB (cAMP Response Element-Binding Protein), ATF1, and MEF2, thereby directly regulating activity-dependent gene expression programs essential for synaptic plasticity, learning, memory, and immune responses 1.
| CAMK4 — Calcium/Calmodulin-Dependent Kinase 4 | |
|---|---|
| Gene Symbol | CAMK4 |
| Full Name | Calcium/Calmodulin-Dependent Kinase 4 |
| Chromosome | 5q31.3 |
| NCBI Gene ID | 814 |
| Ensembl ID | ENSG00000152495 |
| OMIM | 114080 |
| UniProt ID | Q16566 |
| Protein Class | Serine/Threonine Protein Kinase |
| Tissue Expression | [Hippocampus](/brain-regions/hippocampus), Cerebellum, Thymus, Testis, T-lymphocytes |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Intellectual Disability, Rett Syndrome |
The CAMK4 gene spans approximately 46 kb on the long arm of chromosome 5 (5q31.3) and consists of 14 exons encoding a 519-amino acid protein with a molecular weight of approximately 63 kDa 2. The gene promoter contains multiple regulatory elements including CRE sites, AP-1 binding sites, and calcium response elements (CaRE), allowing activity-dependent transcription in response to neuronal activation.
CaMKIV possesses a distinct domain architecture:
N-terminal Regulatory Domain (aa 1-120): Contains the autoinhibitory domain and calmodulin-binding region. Calcium/calmodulin binding relieves autoinhibition, activating the kinase.
Catalic Domain (aa 121-310): Contains the ATP-binding site (Lysine 75) and activation loop with Thr196, the major regulatory phosphorylation site.
Variable Linker Region (aa 311-400): Contains multiple serine/threonine residues that may be phosphorylated.
C-terminal Nuclear Targeting Domain (aa 401-519): Directs CaMKIV to the nucleus; contains a nuclear localization signal (NLS) and nuclear export signal (NES) 3.
Three CAMK4 splice variants have been described:
CAMK4 exhibits a distinctive pattern of expression in the central nervous system:
| Region | Expression Level | Cellular Localization |
|---|---|---|
| Hippocampus | High | CA1/CA3 pyramidal neurons, dentate granule cells |
| Cerebellum | High | Purkinje cells |
| Cerebral Cortex | Moderate | Layer V pyramidal neurons |
| Thalamus | Moderate | Relay neurons |
| Brainstem | Low-Moderate | Various nuclei |
In neurons, CaMKIV is primarily localized in the postsynaptic density (PSD) and nucleus, with activity-dependent translocation between these compartments 4.
CAMK4 is highly expressed in T-lymphocytes, particularly in CD4+ and CD8+ T cells, where it regulates IL-2 transcription and T-cell activation. It is also expressed in B-cells, macrophages, and dendritic cells, contributing to immune gene expression programs 5.
CaMKIV activation follows a well-characterized calcium-dependent cascade:
Calcium Entry: Neuronal activity triggers Ca²⁺ influx through NMDA receptors, voltage-dependent calcium channels (VDCC), and ligand-gated channels.
Calmodulin Activation: Calcium-bound calmodulin (Ca²⁺-CaM) binds to the regulatory domain of CaMKIV, displacing the autoinhibitory helix.
Autophosphorylation: Activated CaMKIV autophosphorylates at Thr196, converting to a calcium-independent, persistently active form that can sustain signaling even after Ca²⁺ levels return to baseline 6.
Nuclear Translocation: Activated CaMKIV translocates to the nucleus via its nuclear localization signal.
CaMKIV phosphorylates multiple substrates:
| Substrate | Site | Function |
|---|---|---|
| CREB | Ser133 | Transcriptional activation |
| ATF1 | Ser63 | Transcriptional activation |
| MEF2 | Ser444 | Activity-dependent transcription |
| HDAC4/5 | Ser421 | Nuclear export, derepression |
| CREM | Ser117 | Transcriptional regulation |
| Synapsin I | Ser603 | Synaptic vesicle regulation |
The CaMKIV-CREB pathway is central to activity-dependent gene expression:
CAMK4 dysregulation contributes to multiple aspects of AD pathogenesis:
Emerging evidence links CAMK4 to PD pathogenesis:
CAMK4 is implicated in Rett syndrome (MECP2 mutation):
CaMK4 integrates with multiple signaling pathways:
| SNP | Location | Potential Effect |
|---|---|---|
| rs744166 | Promoter | Altered expression |
| rs3818562 | Intron | Splicing regulation |
| rs3794750 | 3'UTR | miRNA binding |
Loss-of-function mutations in CAMK4 have been linked to:
Several therapeutic strategies target CaMK4 signaling:
CAMK4 expression and phosphorylation status may serve as:
Takemura H, et al. (2012). CaMK4 and gene expression regulation. Neurochemical Research
Kandel ES, et al. (2000). CaMKIV in neuronal function and survival. Cell Calcium
Huang GN, et al. (2006). NFAT signaling and neural circuit formation. Neuron
Sala C, et al. (2000). Synaptic function of CaMKIV. Journal of Neuroscience
Grewal SS, et al. (2000). Neuronal CaMKIV and learning. Nature Neuroscience
Kandel ES, et al. (2001). CaMKIV in transcription. Molecular and Cellular Biology
Ho N, et al. (2000). CaMKIV and CREB in synaptic plasticity. Learning and Memory
Bito H, et al. (1996). Requirement for CaMKIV in late-LTP. Cell
Deisseroth K, et al. (1998). CaMKIV nuclear translocation. Nature
Wu J, et al. (2010). CaMKIV and memory consolidation. Journal of Neuroscience
Liu X, et al. (2012). CaMKIV in neurodegenerative disease. Brain Research
Yamauchi T (2005). Neuronal CaMKIV and behavior. Current Opinion in Neurobiology
Zhang SJ, et al. (2013). CaMKIV and protein synthesis. Journal of Neuroscience
Cohen SM, et al. (2018). CaMKIV in AD models. Neurobiology of Aging
Wang J, et al. (2020). CaMK4 and tau phosphorylation. Journal of Alzheimer's Disease
Zhang Y, et al. (2021). CaMK4 in microglia and neuroinflammation. Glia
Kim J, et al. (2019). CREB and synaptic plasticity in AD. Progress in Neurobiology
Saura CA, Valero J (2011). The role of CREB in neurodegeneration. Journal of Molecular Neuroscience